Adlai Nortye Group (ANL) vs Seaport Therapeutics (SPTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Adlai Nortye Group is the larger company by market cap ($998.8 million vs $958.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANL | SPTX |
|---|---|---|
| Share price | $15.51 | $17.91 |
| Market cap | $998.81M | $958.73M |
| 1-day change | +10.39% | -0.11% |
| YTD return | +992.25% | — |
| 1-year return | +796.53% | — |
| EPS (TTM) | $-0.66 | $-5.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.25 | $28.38 |
| 52-week low | $0.879 | $14.85 |
| Distance from 52-week high | -10.09% | -36.89% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +90.20% | +113.79% |
| Average volume | 187.30K | 182.18K |
| Shares outstanding | 58.73M | 53.53M |
| Employees | 109 | 58 |
| Sector | Healthcare | Health Care |
| Industry | Biotechnology | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Adlai Nortye Group in Healthcare and Seaport Therapeutics in Health Care.
About Adlai Nortye Group
ANL stock →Adlai Nortye Group Ltd., a clinical-stage biopharmaceutical company, engages in the discovery and development of cancer therapies. The company's pipeline centers on RAS-targeting therapies and next-generation cancer immunotherapies.
Healthcare · Biotechnology · 109 employees
About Seaport Therapeutics
SPTX stock →Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leveraging its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs in depression and anxiety.
Health Care · Biotechnology: Pharmaceutical Preparations · 58 employees
ANL vs SPTX FAQ
Which is bigger, Adlai Nortye Group or Seaport Therapeutics?
Adlai Nortye Group (ANL) is larger, with a market capitalization of $998.81M compared with $958.73M for Seaport Therapeutics (SPTX).
Are Adlai Nortye Group and Seaport Therapeutics in the same industry?
No. Adlai Nortye Group is in the Healthcare sector, while Seaport Therapeutics is in Health Care.